While services and diagnostics define much of today's demand, the oligonucleotide synthesis market is also being shaped by chemistry choices, manufacturing investment, and the growth of nucleic acid medicines. Polaris Market Research reports that the market was valued at USD 3.55 billion in 2025 and is projected to grow from USD 4.07 billion in 2026 to USD 12.49 billion by 2034, at a CAGR of...